Suppr超能文献

药物相互作用。II. 治疗药物中亚硝胺的形成。由亚硝酸盐和仲胺盐酸普萘洛尔形成N-亚硝基普萘洛尔的性质和动力学。

Drug interactions. II. Formation of nitrosamines from therapeutic drugs. Properties and kinetics of the formation of N-nitrosopropranolol from nitrite and the secondary amine propranolol hydrochloride.

作者信息

Chen J, Raisfeld-Danse I H

出版信息

J Pharmacol Exp Ther. 1983 Jun;225(3):705-12.

PMID:6864529
Abstract

In the presence of hydrochloric acid, nitrosamines may be generated from amines and nitrite. Most nitrosamines are carcinogens and many commonly used drugs contain potentially nitrosatable amine groups. Beta-adrenergic blockers, which have such amine groups, are widely prescribed and are often ingested for the lifetime of the patients, but their safety with respect to the intragastric formation of nitrosamines has not been established. The studies in this and the following report were designed to assess the potential risk posed by the endogenous formation of a nitrosamine in the stomach to individuals receiving longterm treatment with propranolol hydrochloride. The putative nitrosamine, N-nitrosopropranolol (NNP), was synthesized and its stability was examined under various experimental conditions. A high-pressure liquid chromatographic method was developed which detects a minimum of 7 X 10(-11) mol of NNP in the presence of large quantities of unreacted drug. Preparations of propranolol hydrochloride were found to contain several non-nitrosamine contaminants, which were removed before kinetic studies. At 37 degrees C, in solutions of HCl within the pH range found in the stomach, the optimum pH for the formation of NNP was 3. The yield of NNP increased linearly as incubation time and concentration of propranolol increased and exponentially as the concentration of nitrite was raised. Under optimal conditions in hydrochloric acid, the minimum concentration of nitrite required for the production of detectable amounts of NNP was 10(-5) M.

摘要

在盐酸存在的情况下,胺类和亚硝酸盐可能会生成亚硝胺。大多数亚硝胺都是致癌物,许多常用药物都含有潜在的可亚硝化的胺基。具有此类胺基的β-肾上腺素能阻滞剂被广泛处方,患者常需终生服用,但它们在胃内形成亚硝胺方面的安全性尚未确定。本报告及后续报告中的研究旨在评估胃内源性形成亚硝胺对接受盐酸普萘洛尔长期治疗的个体所构成的潜在风险。合成了假定的亚硝胺N-亚硝基普萘洛尔(NNP),并在各种实验条件下检测了其稳定性。开发了一种高压液相色谱法,该方法在存在大量未反应药物的情况下,能检测到最低7×10⁻¹¹摩尔的NNP。发现盐酸普萘洛尔制剂含有几种非亚硝胺污染物,在进行动力学研究之前已将其去除。在37℃下,在胃内发现的pH范围内的盐酸溶液中,NNP形成的最佳pH值为3。NNP的产率随着孵育时间和普萘洛尔浓度的增加呈线性增加,随着亚硝酸盐浓度的升高呈指数增加。在盐酸中的最佳条件下,产生可检测量的NNP所需的亚硝酸盐最低浓度为10⁻⁵ M。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验